The results of 5-year experience in testing the glomerular filtration rate by the INVITRO laboratory in the territory of the Russian Federation
- Autores: Fadin D.V1, Fedin V.A2, Zingerman B.V3, Kotenko O.N4, Kargalskaya I.G3
-
Afiliações:
- INVITRO Company
- OOO «INVITRO»
- OOO TelePat
- Moscow City Scientific and Practical Center for Nephrology and Kidney Transplant Pathology City Clinical Hospital № 52 of the Moscow Healthcare Department
- Edição: Volume 13, Nº 2 (2021)
- Páginas: 27-33
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273743
- DOI: https://doi.org/10.18565/nephrology.2021.2.27-33
- ID: 273743
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
D. Fadin
INVITRO CompanyDirector for Strategic Development and Innovation Moscow, Russia
V. Fedin
OOO «INVITRO»General Director Moscow, Russia
B. Zingerman
OOO TelePatScientific Director Moscow, Russia
O. Kotenko
Moscow City Scientific and Practical Center for Nephrology and Kidney Transplant Pathology City Clinical Hospital № 52 of the Moscow Healthcare DepartmentCand. Sci. (Med.), Chief External Expert in Nephrology of the Moscow Healthcare Department, Head Moscow, Russia
I. Kargalskaya
OOO TelePatHead of the Patient-Oriented Telemedicine Committee at the All-Russian Union of Patients Moscow, Russia
Bibliografia
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(2 suppl 1): S1-S266.
- Rettig R.A., Norris K., Nissenson A.R. Chronic kidney disease in the United States: a public policy imperative. Clin J Am Soc Nephrol. 2008;3:1902-1910.
- Melamed M.L., Bauer C., Hostetter T.H. eGFR: is it ready for early identification of CKD? Clin J Am Soc Nephrol. 2008;3(5):1569-1572.
- Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensinconvertingenzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
- Дудко М.Ю., Котенко О.Н., Шутов Е.В., Васина Н.В. Эпидемиология хронической болезни почек среди жителей города Москвы. Клиническая нефрология. 2019;3:37-41.
- Отчет ООО «ИНВИТРО-Объединенные коммуникации» от 18.05.2020. [Report of INVITRO-United Communications LLC dated 18.05.2020 (In Russ.)].
- Hill N.R. et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS ONE. 2016; 11:e0158765.
- Zhang L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012; 379:815-822.
- Arora P. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013;185: E417-E423.
- White S.L., Polkinghorne K.R., Atkins R.C., Chadban S.J. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am. J. Kidney Dis. 2010;55:660-670.
- Levey A.S., Coresh J. Chronic kidney disease. Lancet. 2012;379:165-180.
- Girndt M., Trocchi P., Scheidt-Nave C., Markau S. Stang A. The prevalence of renal failure. Results from the German Health Interview and Examination Survey for Adults, 2008-2011 (DEGS1). Dtsch. Arztebl. Int. 2016;113:85-91.
- Bruck K. et al. CKD prevalence varies across the European general population. J. Am. Soc. Nephrol. 2016;27:2135-2147.
- Fraser S.D. et al. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS ONE 2015;10:e0118676.
- Codreanu I., Perico N., Sharma S.K., et al. Prevention programmes of progressive renal disease in developing nations. Nephrology. 2006;11:321-328.
- Li P.K., Weening J.J., Dirks J., et al. Participants of ISN Consensus: Workshop on Prevention of Progression of Renal Disease. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney Int Suppl. 2005;94:S2-S7.
- Levey A.S., Atkins R., Coresh J., et al: Chronic kidney disease as a global public health problem: Approaches and initiatives - A position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247-259.
- Archibald G., Bartlett W., Brown A., et al. UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant 22:Six4-Six5, 2007;suppl. 9.
- Vassalotti J.A., Stevens L.A., Levey A.S. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169-180.
- Imai E., Yamagata K., Iseki K., et al. Kidney disease screening program in Japan: History, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360-1366.